Abstract
Ion channels are integral membrane proteins that enable the passive flow of inorganic ions by forming hydrated pores across biological membranes. Their pore-forming alpha subunits determine ion permeation and provide the machinery for gating. In addition, channel class specific accessory proteins termed beta, gamma and delta subunits have been found that modulate or even determine key properties like channel gating (e.g. activation, inactivation properties), surface expression, targeting and stability. Moreover, some of these subunits constitute binding sites for toxins as well as for therapeutic drugs. With the development of more powerful proteomic and molecular biology-based methods, a vastly increasing number of proteins interacting with ion channels has recently been described. These results are providing novel insight into ion channel function and at the same time challenging classical concepts of beta subunits and ion channel drug targets. They are also raising questions about functional validation and reliability of these methods. This review focuses on the potentials and limitations of modern “-omic” protein-protein interaction analyses and their application to ion channels. After recapitulating fundamental thermodynamic and biochemical principles underlying protein-protein interactions, current methods for their systematic identification are critically reviewed. Selected examples of newly characterized ion channel complexes will then be discussed to illustrate the implications for molecular understanding as well as for the effective selection and screening of ion channel drug targets.
CNS & Neurological Disorders - Drug Targets
Title: Protein-Protein Interactions and Subunit Composition of Ion Channels
Volume: 7 Issue: 2
Author(s): Uwe Schulte
Affiliation:
Abstract: Ion channels are integral membrane proteins that enable the passive flow of inorganic ions by forming hydrated pores across biological membranes. Their pore-forming alpha subunits determine ion permeation and provide the machinery for gating. In addition, channel class specific accessory proteins termed beta, gamma and delta subunits have been found that modulate or even determine key properties like channel gating (e.g. activation, inactivation properties), surface expression, targeting and stability. Moreover, some of these subunits constitute binding sites for toxins as well as for therapeutic drugs. With the development of more powerful proteomic and molecular biology-based methods, a vastly increasing number of proteins interacting with ion channels has recently been described. These results are providing novel insight into ion channel function and at the same time challenging classical concepts of beta subunits and ion channel drug targets. They are also raising questions about functional validation and reliability of these methods. This review focuses on the potentials and limitations of modern “-omic” protein-protein interaction analyses and their application to ion channels. After recapitulating fundamental thermodynamic and biochemical principles underlying protein-protein interactions, current methods for their systematic identification are critically reviewed. Selected examples of newly characterized ion channel complexes will then be discussed to illustrate the implications for molecular understanding as well as for the effective selection and screening of ion channel drug targets.
Export Options
About this article
Cite this article as:
Schulte Uwe, Protein-Protein Interactions and Subunit Composition of Ion Channels, CNS & Neurological Disorders - Drug Targets 2008; 7 (2) . https://dx.doi.org/10.2174/187152708784083795
DOI https://dx.doi.org/10.2174/187152708784083795 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Novel Treatments in Subarachnoid Hemorrhage
The current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a ...read more
Pathogenic Proteins in Neurodegenerative Diseases: From Mechanisms to Treatment Modalities
The primary objective of this thematic issue is to elucidate the molecular mechanisms by which pathogenic proteins contribute to neurodegenerative diseases and to highlight current and emerging therapeutic strategies aimed at mitigating their effects. By bringing together cutting-edge research and reviews, this issue aims to: 1.Enhance Understanding: Provide a comprehensive ...read more
Role of glial cells in autism spectrum disorder: Molecular mechanism and therapeutic approaches
Emerging evidence suggests that glial cells may play a pivotal role in neuroanatomical and behavioral changes found in autism spectrum disorder (ASD). Many individuals with ASD experience a neuro-immune system abnormalities throughout life, which implicates a potential role of microglia in the pathogenesis of ASD. Dysfunctional astrocytes and oligodendrocytes were ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in the Physiology of GPR55 in the Central Nervous System
Current Neuropharmacology Xenosensors CAR and PXR at Work: Impact on Statin Metabolism
Current Drug Metabolism Preface [Hot Topic: Rational Drug Design and The Discovery of the 1,2,3-Triazolines as a Unique Class of Anticonvulsants and Antiischemic Agents (Guest Editor: Pankaja K. Kadaba)]
Current Medicinal Chemistry Autoimmunity and Frontotemporal Dementia
Current Alzheimer Research Sympathetic Nervous System Dysfunction in Multiple Sclerosis, Linking Neurodegeneration to a Reduced Response to Therapy
Current Pharmaceutical Design Therapeutic Potential of Metabotropic GABA (GABAB) Receptors and their Effector Ion Channels
Central Nervous System Agents in Medicinal Chemistry Routine Collection of Patient-Reported Outcomes in an HIV Clinic Setting:The First 100 Patients
Current HIV Research Methods to Assess Tissue-Specific Distribution and Metabolism of Drugs
Current Drug Metabolism Survey of Recent Literature Related to the Biologically Active 4(3H)-Quinazolinones Containing Fused Heterocycles
Current Medicinal Chemistry Madecassic Acid Reduces Fast Transient Potassium Channels and Promotes Neurite Elongation in Hippocampal CA1 Neurons
CNS & Neurological Disorders - Drug Targets Classification of Normal and Epileptic EEG Signals Using Adaptive Neuro-Fuzzy Network Based on Time Series Prediction
Neuroscience and Biomedical Engineering (Discontinued) Bipolar Affective Disorder in Young People: A Review
Adolescent Psychiatry Lexical Characterisation of Bio-Ontologies by the Inspection of Regularities in Labels
Current Bioinformatics The Metabolism of Methazolamide - Identification of Metabolites in Guinea Pig Urine
Drug Metabolism Letters Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy
Current Drug Targets Infantile Epileptic Encephalopathy with Hypsarrhythmia (Infantile Spasms/West Syndrome) and Immunity
Central Nervous System Agents in Medicinal Chemistry Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article
CNS & Neurological Disorders - Drug Targets Patent Selections :
Recent Patents on CNS Drug Discovery (Discontinued) The Role of P-Glycoprotein in Psychiatric Disorders: A Reliable Guard of the Brain?
Central Nervous System Agents in Medicinal Chemistry Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets